Depression can be one of the most difficult conditions to understand, particularly when someone has tried treatment after treatment without experiencing meaningful relief. For some, depression arrives following childbirth. For others, it develops gradually, following years of stress, illness, loss, or circumstances that seem impossible to escape.
Some experience recurring depressive episodes, while others struggle with bipolar disorder, where periods of depression may alternate with mania or hypomania. And then there are people living with treatment-resistant depression.
They have tried medications, counseling, lifestyle changes, and sometimes specialized interventions. Yet meaningful improvement remains elusive.
What happens when someone in that position experiences an unexpected recovery? And what should we make of reports that chlorine dioxide, a compound best known for water treatment and antimicrobial activity, has played a role in some of those recoveries?
Herb Roi Richards, author of Chlorine Dioxide for Humans: Recipes and Treatment, has expressed considerable confidence in chlorine dioxide’s potential for depression, including treatment-resistant cases, based on his field observations.
Those reports are not clinical proof. But they raise questions worth investigating, particularly as researchers continue discovering connections among gut microorganisms, immune signaling, metabolism, and the brain.
Perhaps the most useful place to begin is with a question: What changed first?
Depression Is More Than a Chemical Imbalance
For many years, depression was commonly explained as a problem involving insufficient serotonin or other neurotransmitters. Today, researchers recognize a much more complicated picture. Neurotransmitters remain important, but depression can involve changes in stress regulation, sleep, neural circuits, immune signaling, metabolism, and other biological processes.
Depression also involves psychological and social factors. Relationships, trauma, chronic stress, financial insecurity, isolation, and major life changes can influence its development and persistence.
Not every person with depression has the same underlying difficulties. That matters because two people may experience similar depressive symptoms for very different reasons.
A treatment that helps one person may accomplish little for another. And an improvement in depression may sometimes begin somewhere other than the brain itself.
Treatment-Resistant Depression: When Nothing Seems to Work
Treatment-resistant depression generally refers to major depression that has not responded adequately to at least two appropriate antidepressant treatment trials, although definitions vary.
For someone living with it, the experience can be exhausting. A new treatment brings hope. Weeks pass. Sometimes there is a little improvement, followed by disappointment. Another treatment begins, and the cycle repeats.
Eventually, the person may begin to believe that recovery is simply not possible. Yet treatment resistance does not mean the brain has permanently lost its capacity to improve.
Some people respond to subsequent treatments, combinations of therapies, or specialized approaches such as transcranial magnetic stimulation, electroconvulsive therapy, or ketamine-based treatment under medical supervision. Others experience improvements that are difficult to attribute to any single intervention.
This is particularly interesting when considering reports involving unconventional approaches.
If someone with treatment-resistant depression experiences an unexpected improvement after trying chlorine dioxide, several questions immediately arise.
- Was there a direct biological effect?
- Did another treatment begin working?
- Did sleep or physical health improve?
- Did the person’s expectations change?
- Or did several influences converge at approximately the same time?
The improvement may be real even when its cause remains uncertain.

Herb Roi Richards and Reports of Depression Improvement
Herb Roi Richards’ interest in chlorine dioxide extends well beyond its established use in water treatment. Through his field work, Herb has discussed reported improvements involving numerous health conditions, including depression and other neurological or cognitive complaints.
His confidence in chlorine dioxide for depression, particularly treatment-resistant depression, reflects the experiences and reports he has encountered. The important distinction is between what has been reported and what has been demonstrated.
A person reporting relief from depression after using chlorine dioxide is describing an experience. That experience may deserve investigation, but it does not establish that chlorine dioxide produced the improvement. Nor does chlorine dioxide’s antimicrobial chemistry establish that it has an antidepressant effect.
Nevertheless, there is a broader scientific question worth exploring. Could changes elsewhere in the body influence depressive symptoms?
Research into the microbiota–gut–brain axis suggests that, under some circumstances, they can.
The Gut-Brain Connection: Two-Way Communication
The gut and brain are in continuous communication.
This communication involves the nervous system, immune system, hormones, microbial metabolites, and other chemical messengers. Researchers often refer to these interacting pathways as the microbiota–gut–brain axis.
The intestinal microbiome contains trillions of microorganisms that participate in digestion, nutrient metabolism, and the production or modification of biologically active compounds. Some of these compounds may influence immune responses, stress regulation, and nervous-system activity.
The communication also works in the opposite direction. Stress can affect intestinal movement, secretion, permeability, and microbial communities.
This creates an important possibility: depression and changes in gut function may sometimes influence one another.
Researchers have identified associations between depression and differences in gut microbial composition, although the findings vary across studies and individuals.
Those associations do not mean that depression is simply caused by an unhealthy microbiome. They do suggest that the gut-brain connection deserves serious attention.
What Fecal Microbiota Transplantation Reveals
One of the more unusual developments in microbiome research involves fecal microbiota transplantation, commonly abbreviated FMT. FMT involves transferring processed intestinal microorganisms from a screened donor to a recipient.
Its established medical role is primarily in selected cases of recurrent Clostridioides difficile infection. Researchers are also investigating its potential for other conditions, including psychiatric and neurological disorders.
Experimental studies have produced intriguing findings. In some animal experiments, transferring intestinal microorganisms from animals exposed to chronic stress has influenced anxiety-like or depression-like behaviors in recipients.
Human studies are exploring whether microbiome interventions, including FMT, might improve depressive symptoms in selected populations.
These findings are preliminary, but they suggest that changing an intestinal microbial community can sometimes influence processes relevant to emotional functioning.
That possibility becomes especially interesting when considering an unusual anecdote involving a married couple.
The Spouse Who Reportedly Lost Depression but Developed Anxiety
An anecdotal account describes a person experiencing depression who received a do-it-yourself fecal microbiota transplant from their spouse. Following the procedure, the recipient reportedly experienced substantial relief from depression. But there was an unexpected development.
The recipient also reportedly began experiencing anxiety resembling the donor spouse’s anxiety.
The story is intriguing, although the specific case has not been independently verified here. It cannot establish that depression was cured or that anxiety was biologically transferred between spouses.
Nevertheless, it raises a fascinating research question. Could transferring a microbial community influence multiple aspects of emotional functioning, potentially improving some symptoms while worsening others?
Animal research provides reasons to investigate that possibility, but human emotional states are far too complex to describe anxiety or depression as something that can simply be transplanted from one person to another.
Donor characteristics, microbial metabolites, immune responses, existing health conditions, and psychological factors could all matter.
The account also illustrates why FMT requires carefully screened donors and medical supervision. Unscreened transfers can introduce dangerous infections.
Still, the broader implication is significant. Changing the gut may sometimes influence systems far beyond digestion. And that brings us back to depression.
New Clinical Research: Changing Gut Microbes May Influence Depression
A randomized, double-blind, placebo-controlled clinical trial published in Cell Host & Microbe in July 2026 provides an especially interesting example.
Researchers investigated whether fecal microbiota transplantation could improve outcomes for people with major depressive disorder who were also receiving the antidepressant escitalopram.
Participants received either FMT capsules or placebo capsules alongside their medication.
The researchers found greater reductions in depression scores in the FMT group at two and eight weeks. They also documented changes in intestinal microorganisms, bile-acid metabolism, and inflammatory signaling.
Importantly, remission rates at eight weeks were not significantly different between groups. The findings suggest a potentially useful additional treatment pathway, not a demonstrated cure.
This is significant because researchers weren’t simply asking whether people felt better. They were investigating what changed biologically alongside the improvement.
A 2025 meta-analysis of 12 randomized trials involving 681 participants also reported reductions in depressive symptoms following FMT, although results varied among populations and benefits appeared less durable over longer follow-up.
Not every review has reached the same conclusion. Another analysis of seven trials found insufficient evidence for a statistically significant overall benefit, underscoring the need for larger, better-controlled studies.
Nevertheless, the research supports continued investigation of microbial influences on mood.

Does This Explain Chlorine Dioxide’s Reported Effects?
Not yet. Chlorine dioxide is an oxidizing antimicrobial. Its chemistry is well established in water disinfection and certain industrial applications. What remains unestablished is whether exposure to chlorine dioxide produces beneficial changes in the human intestinal microbiome, immune signaling, or neurological function.
In fact, antimicrobial activity does not necessarily mean improved microbial balance. Disrupting microorganisms can sometimes be harmful, and ingesting chlorine dioxide can cause serious adverse effects. But the broader biological question is worth separating from the specific substance.
If depression can sometimes be influenced by changes in intestinal microorganisms, microbial metabolites, or immune signaling, then an improvement in depression need not originate exclusively within the brain.
That is a meaningful development in our understanding of depression. It provides a possible framework for investigating unusual recovery reports, although it does not establish chlorine dioxide as a safe or effective way to influence those pathways.
Could Hope and Expectation Also Change the Outcome?
There is another dimension to consider. Imagine someone who has lived with depression for years. They have tried multiple treatments. Their confidence in recovery has gradually diminished. Then they encounter an unfamiliar approach presented by someone they trust.
For the first time in years, they begin expecting improvement. That expectation may influence motivation, sleep, stress responses, activity, relationships, and engagement with recovery.
Psychological expectations can also influence physiological processes.
This is part of the scientific interest surrounding placebo effects and mind-body interactions. The effects are not necessarily imaginary. Changes in symptoms, behavior, and physiological responses can be genuine even when the intervention itself lacks a specific therapeutic action.
But expectation alone does not explain every recovery, and a reported improvement cannot automatically be attributed to placebo.
The more useful question is whether psychological and biological influences may sometimes operate together.
The Visualization Movement and the Biology of Hope
During the late 1970s and early 1980s, physician O. Carl Simonton and colleagues helped popularize visualization exercises among people living with cancer. Patients were encouraged to imagine their immune systems responding to cancer and their tumors shrinking.
The approach attracted considerable attention and became part of a broader movement exploring the relationship between psychological experience and physical health.
Although subsequent research has not established visualization alone as a reliable way to reverse cancer, imagery and relaxation techniques have demonstrated value for certain psychological outcomes, including distress and quality of life.
The historical importance of the movement lies partly in its willingness to investigate interactions among the mind, nervous system, hormones, and immune system. Those interactions are now studied through fields such as psychoneuroimmunology. And they remind us that emotional experience and physical biology are not completely separate worlds.
Four Different Forms of Depression, Four Different Questions
Major Depressive Disorder
Major depressive disorder may involve persistent sadness, loss of interest, fatigue, cognitive difficulties, sleep changes, and other symptoms.
Researchers are investigating how immune activity, metabolism, sleep, and gut-brain communication may contribute to different patterns of depression.
An improvement in one of these systems could potentially influence symptoms, although the importance of each pathway varies among individuals.
Treatment-Resistant Depression
Treatment-resistant depression is especially relevant to Herb Roi Richards’ observations. When established treatments have not provided adequate relief, an unexpected improvement can be particularly meaningful.
However, identifying the cause requires careful attention to previous treatments, medication changes, symptom history, expectations, and the duration of recovery.
A sustained improvement documented through standardized assessments would provide considerably more useful information than an isolated report of feeling better.
Postpartum Depression
Postpartum depression occurs in a period of substantial hormonal, immune, physical, and psychological change. Sleep disruption, stress, prior mental-health history, and other factors may contribute.
Researchers are also exploring possible relationships among the maternal microbiome, immune function, and postpartum mental health. These investigations are preliminary and do not establish chlorine dioxide as a postpartum depression treatment.
Because postpartum depression can become severe, timely professional assessment and appropriate care are especially important.
Bipolar Depression
Bipolar disorder presents a different challenge. A person may experience significant depressive episodes alongside periods of mania or hypomania.
An apparent sudden recovery from depression must therefore be interpreted carefully.
Increased energy, reduced need for sleep, and unusually elevated mood can sometimes signal a developing manic or hypomanic episode rather than stable recovery. For this reason, any reported improvement involving bipolar depression needs documentation of mood stability over time.
What Should We Measure When Someone Reports Improvement?
The most useful investigations would begin before the intervention, whenever possible. Researchers could document the person’s diagnosis, treatment history, symptom severity, sleep patterns, physical health, medications, and other relevant factors.
If the microbiota–gut–brain axis is part of the hypothesis, measurements might also include intestinal microbial composition, selected microbial metabolites, metabolic markers, and inflammatory indicators.
Follow-up assessments could then establish whether changes in these measures preceded, accompanied, or followed improvement in depressive symptoms.
Several possible outcomes would be informative.
- Perhaps sleep improves before mood.
- Perhaps digestive symptoms improve first.
- Perhaps inflammatory markers change.
- Perhaps motivation returns before the person reports feeling less depressed.
- Perhaps no consistent biological pattern emerges.
- Or perhaps improvement occurs without any measurable relationship to the intervention being investigated.
Each outcome would help narrow the possibilities.
What Changed First?
The growing body of research on depression challenges the idea that every depressive episode can be explained by one simple chemical imbalance. Depression involves interacting biological, psychological, and social systems.
The gut-brain axis adds another layer to that complexity.
Research involving FMT suggests that changing intestinal microbial communities may influence depressive symptoms in some circumstances, although the clinical applications remain under investigation.
Research into expectancy and mind-body interactions shows that beliefs, experiences, and psychological context can also influence recovery.
Neither finding proves that chlorine dioxide treats depression. But both help us ask more sophisticated questions about the improvements reported by Herb Roi Richards and others.
- Perhaps some recoveries involve changes in physical health.
- Perhaps some involve changes in expectations and behavior.
- Perhaps several systems begin changing together.
- And perhaps future investigations will reveal patterns that have not yet been recognized.
The important thing is to distinguish the recovery someone experiences from the explanation attached to it.
- A person can improve without fully understanding why.
- A practitioner can observe a recurring pattern without knowing its mechanism.
- And researchers can investigate those observations without assuming that every proposed explanation is correct.
The most interesting part of a recovery may not be the remedy someone used.
It may be discovering which part of the person began recovering first.
That is where the next chapter of investigation begins.
Research References
- Li J, et al. (2026). Adjunctive fecal microbiota transplantation for major depressive disorder: A randomized, double-blind, placebo-controlled trial. Cell Host & Microbe. Read the study.
- Zhang X, et al. (2025). Clinical efficacy of fecal microbiota transplantation in alleviating depressive symptoms: A meta-analysis of randomized trials. Frontiers in Psychiatry. Read the meta-analysis.
- Efficacy effects of fecal microbiota transplantation on depressive symptoms: A meta-analysis based on randomized controlled trials. Read the review.
- Current landscape of fecal microbiota transplantation in treating depression. Frontiers in Immunology (2024). Read the review.
Informational Notice: This article examines practitioner observations, personal reports, and emerging research into depression and the microbiota–gut–brain axis. Chlorine dioxide has not been established as a safe or effective treatment for depression, and ingesting it can cause serious harm. FMT for psychiatric conditions remains investigational. Neither should replace established mental-health care, and prescribed psychiatric medications should not be discontinued without medical guidance.




















